Trials / Completed
CompletedNCT04496141
Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (actual)
- Sponsor
- Hong Kong Sanatorium & Hospital · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Achieved serum samples of persons with or without evidence of COVID-19 infection are tested using the different commercial SARS-CoV-2 antibody immunoassays. The performance of the immunoassays is then assessed by comparing the 2 groups of samples.
Detailed description
Achieved serum samples of the different testing groups are retrieved and tested with the immunoassays according to manufacturer's instruction. The test results are then compared and analyzed with statistical tests to assess the immunoassays'performance
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | SARS-CoV-2 antibody immunoassays | Different commercial SARS-CoV-2 antibody immunoassays |
Timeline
- Start date
- 2020-07-27
- Primary completion
- 2020-08-31
- Completion
- 2020-08-31
- First posted
- 2020-08-03
- Last updated
- 2024-02-28
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT04496141. Inclusion in this directory is not an endorsement.